Generate Biomedicines Balance Sheet
NASDAQ: GENBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Generate Biomedicines has no annual balance sheet on file yet, so quarterly figures are shown instead.
Generate Biomedicines financial position
As of Jun 30, 2026, Generate Biomedicines reported total assets of $561.7 million against total liabilities of $105.6 million. Shareholders' equity stood at $456.0 million, or 81.2% of assets. The company held $135.4 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 8.30, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Generate Biomedicines balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Cash & Equivalents | 135.36M | 160.57M | 154.26M | 220.61M |
| Short-Term Investments | 322.06M | 356.07M | — | — |
| Total Current Assets | 470.25M | 535.39M | — | — |
| Property, Plant & Equipment | 27.30M | 27.84M | — | — |
| Total Assets | 561.69M | 625.74M | — | — |
| Accounts Payable | 5.65M | 7.62M | — | — |
| Total Current Liabilities | 56.64M | 58.39M | — | — |
| Total Liabilities | 105.64M | 110.94M | — | — |
| Shareholders' Equity | 456.05M | 514.80M | -517.85M | -471.00M |
| Retained Earnings | -804.99M | -737.74M | — | — |
| Net Cash (Debt) | 457.42M | 516.64M | 154.26M | 220.61M |
| Shares Outstanding | 128.27M | 128.19M | — | — |
This table shows 4 quarterly periods of Generate Biomedicines's balance sheet, from Q2 2026 back to Q? 2025, across 12 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow GENB's reporting calendar. What is a balance sheet?